Exelixis | EXEL - Eps Gewinn Pro Aktie

Aktienkurs
41.27
Täglich Wechseln
0.01 0.02%
Monatlich
-6.23%
Jährlich
11.66%
Q1 Prognose
40.03

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 0.76 0.62 May/06 2026
FY2025Q4 Dec/2025 0.97 0.76 0.55 Feb/10 2026
FY2025Q3 Sep/2025 0.78 0.68 0.47 Nov/04 2025
FY2025Q2 Jun/2025 0.75 0.64 0.84 Jul/28 2025
FY2025Q1 Mar/2025 0.62 0.37 0.17 May/13 2025




Eps Veränderung Datum
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Akebia Therapeutics USD -0.04 0.04 2025-12
Amgen USD 5.29 0.35 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Bayer EUR 0.62 0.05 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Cytokinetics USD -1.5 1.05 2025-12
Eisai JPY 60.94 24.92 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Exelixis USD 0.97 0.19 2025-12
Genmab DKK 3.69 2.77 2025-12
Glaxosmithkline GBP 0.21 0.51 2025-12
Incyte USD 1.8 0.46 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
MacroGenics USD -0.22 0.49 2025-12
Merck USD 2.04 0.54 2025-12
Moderna USD -2.11 1.6 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 1.54 0.5 2025-12
Pfizer USD 0.66 0.21 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Sanofi EUR -0.67 3.62 2025-12
Takeda JPY 65.74 73.57 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Xencor USD -0.09 0.01 2025-12